ENTITY

Tg Therapeutics (TGTX US)

2
Analysis
Health CareUnited States
TG Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on the acquisition, development and commercialization of innovative pharmaceutical products for the treatment of cancer and other underserved therapeutic needs. Currently, the company is developing two therapies targeting hematological malignancies, specifically, relapsed and refractory non-Hodgkins lymphoma.
more
Company Event28 Feb 2025 22:30 • Upcoming
Add To Calendar
Company Event04 Nov 2024 21:30 • Latest
Company Event06 Aug 2024 20:30
Company Event01 May 2024 20:30
Company Event28 Feb 2024 21:30
x